Haoxi Health Technology Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
11 2월 2025 - 10:30PM
Haoxi Health Technology Limited (the “Company” or “HAO”), an online
marketing solution provider headquartered in Beijing, China, today
announced that it received a formal notification from the Nasdaq
Stock Market LLC (“Nasdaq”) that the Company has regained
compliance with Nasdaq Listing Rule 5550(a)(2), which requires the
Company’s Class A ordinary shares, par value US$0.0025 each (the
“Ordinary Shares”) to maintain a minimum bid price of $1.00 per
share.
The Nasdaq staff made this determination of
compliance after the closing bid price of the Company’s Ordinary
Shares has been at $1.00 per share or greater for the last 10
consecutive business days from January 27, 2025, to February 7,
2025. Accordingly, the Company has regained compliance with Nasdaq
Listing Rule 5550(a)(2) and this bid price deficiency matter is now
closed.
About Haoxi Health Technology Limited
Haoxi Health Technology Limited is an online
marketing solution provider headquartered in Beijing, China,
specializing in serving healthcare industry advertiser clients. The
Company’s growth is driven by the rise of news feed ads and the
rapid development of the healthcare sector. The Company offers
one-stop online marketing solutions, especially in online short
video marketing, helping advertisers acquire and retain customers
on popular platforms in China, such as Toutiao, Douyin, WeChat, and
Sina Weibo. The Company is dedicated to reducing costs, increasing
efficiency, and providing easy online marketing solutions to
advertisers. For more information, please visit:
http://ir.haoximedia.com .
Forward-Looking Statement
This press release contains forward-looking
statements as defined by the Private Securities Litigation Reform
Act of 1995. Forward-looking statements include statements
concerning plans, objectives, goals, strategies, future events or
performance, underlying assumptions, and other statements that are
other than statements of historical facts. When the Company uses
words such as "may, "will, "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's goals and strategies; the Company's
forecast on market trends; the Company's future business
development; the demand for and market acceptance for new services;
expectation to receive customer orders for new services; the
anticipated timing for the marketing and sales of new solutions;
changes in technology; the Company's ability to attract and retain
skilled professionals; client concentration; and general economic
conditions affecting the Company's industry and assumptions
underlying or related to any of the foregoing and other risks
contained in reports filed by the Company with the SEC. For these
reasons, among others, investors are cautioned not to place undue
reliance upon any forward-looking statements in this press release.
Additional factors are discussed in the Company's filings with the
SEC, which are available for review at www.sec.gov. The
Company undertakes no obligation to publicly revise these
forward-looking statements to reflect events or circumstances that
arise after the date hereof.
For more information, please contact:
Investor Relations
WFS Investor Relations Inc.
Janice Wang, Managing Partner
Email: services@wealthfsllc.com
Phone: +86 13811768599
+1 628 283 9214
Haoxi Health Technology (NASDAQ:HAO)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Haoxi Health Technology (NASDAQ:HAO)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025